Cosmos Health Inc(COSM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 16 at 4:00 AM ET (Korea 9/16 17:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.65 | Insider Own | 21.7% | Shs Outstand | 80.7M | Perf Week | 2.66% |
| Market Cap | 0.03B | Forward P/E | 3.97 | EPS next Y | 133.33% | Insider Trans | 3.13% | Shs Float | 78.8M | Perf Month | 27.4% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.05 | Inst Own | 2.09% | Short Float | 5.17% | Perf Quarter | 17.08% |
| Income | -0.02B | P/S | 0.38 | EPS this Y | 66.67% | Inst Trans | 4.57% | Short Ratio | 0.42 | Perf Half Y | -20.69% |
| Sales | 0.07B | P/B | 1.08 | EPS next 5Y | - | ROA | -39.56% | Short Interest | 4.08M | Perf YTD | -44.26% |
| Book/sh | 0.26 | P/C | 11.26 | EPS past 3/5Y | 73.29% - | ROE | -104% | 52W High | -78.97% ($1.32) | Perf Year | -69.16% |
| Cash/sh | 0.02 | P/FCF | - | Sales past 3/5Y | 9.04% 3.33% | ROIC | -101.02% | 52W Low | 71.78% ($0.16) | Perf 3Y | -80.03% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.05% | Gross Margin | 8.39% | Volatility(W/M) | 10.21% 10.42% | Perf 5Y | -99.77% |
| Dividend TTM | - | EV/Sales | 0.57 | Sales Y/Y TTM | 33.82% | Oper. Margin | -24.65% | ATR (14) | 0.02 | Perf 10Y | -99.81% |
| Dividend Ex-Date | - | Quick Ratio | 0.92 | EPS Q/Q | -3.25% | Profit Margin | -33.08% | RSI (14) | 63.71 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.05 | Sales Q/Q | 28.76% | SMA20 | 17.78% ($0.24) | Beta | 4.29 | Target Price | $4.5 |
| Payout | - | Debt/Eq | 0.8 | Earnings | 2026/8/19 | SMA50 | 19.05% ($0.24) | Rel Volume | 0.3 | Prev Close | $0.27 |
| Employees | 163 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | - 1.75% | SMA200 | -18.4% ($0.34) | Avg Volume(3M) | 9.74M | Price | $0.28 |
| IPO | 2010/7/23 | Option/Short | Yes/Yes | Trades | 1994 | Volume | 2,880,880 | Change | 3.08% |
Company
COSM is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 It is a Greece-based, vertically integrated healthcare group. The structure combines pharmaceutical and health-functional food wholesale distribution, CMO/CDMO production at its own factory (Cana Laboratories), sales of its own brands such as Sky Premium Life, and a UK-based wholesale subsidiary, making it one of the European small-cap healthcare companies with notably strong growth momentum.
Over the past 1 year, on the lower side
79% below its 1-year high.
COSM has weak earning power
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +66.7% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to miss estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -80.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 2.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DFE 0.00%
DLS 0.00%
DDLS 0.00%
AVDV 0.00%
GWX 0.00%It ranks #4 in the industry
Based on market cap of $28M.
COSM $28M PER -
MCK $105B PER 24.1
COR $62B PER 24.0
CAH $54B PER 32.1
FAQ
What kind of company is COSM?
COSM belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of COSM?
The market cap of COSM is approximately $28M, ranking 5,170 within its sector.
What is the 52-week high and low for COSM?
COSM has recorded a 52-week high of $1.32 and a low of $0.16.
